FMR CORP 13D and 13G filings for Bicara Therapeutics Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-03 09:14 am Purchase |
2025-02-24 | 13G | Bicara Therapeutics Inc. Common Stock BCAX |
FMR CORP | 2,803,807 5.200% |
686,719 (+32.44%) |
Filing |
| 2025-02-12 09:16 am Sale |
2024-12-31 | 13G | Bicara Therapeutics Inc. Common Stock BCAX |
FMR CORP | 2,117,088 3.900% |
-378,245 (-15.16%) |
Filing |
| 2024-09-18 11:57 am Purchase |
2024-09-18 | 13G | Bicara Therapeutics Inc. Common Stock BCAX |
FMR CORP | 2,495,333 5.095% |
2,495,333 (New Position) |
Filing |